Trinity Capital (TRIN) announced the commitment of $50M in growth capital to Cala Health, a bioelectronic medicine company developing wearable neuromodulation therapies for tremors.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TRIN:
- Trinity Capital Announces Strong Q1 2026 Investment Activity
- Trinity Capital participates in a conference call with Clear Street
- Trinity Capital provides $50M in growth capital to Sage Health
- Trinity Capital management to meet virtually with Citizens
- 3 High-Yield Dividend Stocks to Buy in Today’s Volatile Market, According to Analysts, 3/18/2026
